Get started
argenx SE Sponsored ADRargenx SE Sponsored ADRargenx SE Sponsored ADR

argenx SE Sponsored ADR

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪50.70 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
41.70
Basic EPS (TTM)
21.29 USD
Net income (FY)
‪831.57 M‬ USD
Revenue (FY)
‪2.19 B‬ USD
Shares float
‪61.69 M‬
Beta (1Y)
0.36

About argenx SE


Sector
Health Technology
Industry
Biotechnology
CEO
Tim van Hauwermeiren
Website
argen-x.com
Headquarters
Amsterdam
Founded
2008
IPO date
Jul 10, 2014
Identifiers
3
ISIN US04016X1019
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Check out other big names from the same industry as ARGX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IBB
iShares Biotechnology ETF
Weight
2.80%
Market value
‪238.75 M‬
USD
FBT
First Trust NYSE Arca Biotechnology Index Fund
Weight
3.45%
Market value
‪83.40 M‬
USD
CGGO
Capital Group Global Growth Equity ETF
Weight
0.88%
Market value
‪76.90 M‬
USD
AVDE
Avantis International Equity ETF
Weight
0.13%
Market value
‪17.76 M‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.83%
Market value
‪17.36 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
1.83%
Market value
‪17.36 M‬
USD
BBH
VanEck Biotech ETF
Weight
4.47%
Market value
‪17.31 M‬
USD
QQQJ
Invesco NASDAQ Next Gen 100 ETF
Weight
1.14%
Market value
‪10.25 M‬
USD
DFAI
Dimensional International Core Equity Market ETF
Weight
0.07%
Market value
‪9.30 M‬
USD
FGEP
Fidelity Global Equity+ Fund Trust Units
Weight
0.15%
Market value
‪7.94 M‬
USD
SBIO
Invesco NASDAQ Biotech UCITS ETF
Weight
1.84%
Market value
‪7.80 M‬
USD

Explore more ETFs